참고문헌
- Adam BL, Qu Y, Davis JW, et al (2002). Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res, 62, 3609-14.
- DiMagno EP, Reber HA, Tempero MA (1999). Epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. Gastroenterology, 117, 1463-84. https://doi.org/10.1016/S0016-5085(99)70297-0
- Ebert MP, Meuer J, Wiemer JC, et al (2004). Identification of gastric cancer patients by serum protein profiling. J Proteome Res, 3, 1261-6. https://doi.org/10.1021/pr049865s
- Guo R, Pan C, Shen J, et al (2011). New serum biomarkers for detection of esophageal carcinoma using Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. J Cancer Res Clin Oncol, 137, 513-9. https://doi.org/10.1007/s00432-010-0899-3
- Hortin GL (2006). The MALDI-TOF mass spectrometric view of the plasma proteome and peptidome. Clin Chem, 52, 1223-37. https://doi.org/10.1373/clinchem.2006.069252
- Liu C, Pan C, Shen J, et al (2011). MALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of colorectal cancer. Int J Med Sci, 8, 39-47. https://doi.org/10.7150/ijms.8.39
- Liu C, Wang H, Pan C, et al (2010). Serum protein fingerprint of patients with gastric cancer by SELDI technology. African J Biotechnol, 9, 2298-304.
- Kim JE, Lee KT, Lee JK, et al (2004). Clinical usefulness of Carbohydrate antigen 199 as a screening test for pancreatic cancer in an asymptomatic population. J Gastroenterol Hepatol, 19, 182-6. https://doi.org/10.1111/j.1440-1746.2004.03219.x
- Kim EJ, Simeone DM, (2011). Advances in pancreatic cancer. Curr Opin Gastroenterol, 27, 460-6. https://doi.org/10.1097/MOG.0b013e328349e31f
- Liang Y, Fang M, Li J, et al (2006). Serum proteomic patterns for gastric lesions as revealed by SELDI mass spectrometry. Exp Mol Pathol, 81, 176-80. https://doi.org/10.1016/j.yexmp.2006.04.008
- Li D, Xie K, Wolff R, et al (2004). Pancreatic cancer. Lancet, 363, 1049-57. https://doi.org/10.1016/S0140-6736(04)15841-8
- Liotta LA, Ferrari M, Petricoin E (2003). Clinical proteomics: written in blood. Nature, 425, 905. https://doi.org/10.1038/425905a
- Liu CB, Liang Y, Pan CQ, et al (2009). Proteome study of differential protein expression in HBV-related primary hepatic carcinoma. Chem J Chinese Universities, 30, 1763-6.
- Liu C, Shen J, Pan C, et al (2010). MALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of hepatocellular carcinoma. Am J Clin Pathol, 134, 235-41 https://doi.org/10.1309/AJCPA6C6NOGFLYIR
- Schwegler EE, Cazares L, Steel LF, et al (2005). SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma. Hepatology, 41, 634-42. https://doi.org/10.1002/hep.20577
- Semmes OJ, Feng Z, Adam BL, et al (2005). Evaluation of serum protein profiling by surface-enhanced laser desorption/ ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility. Clin Chem, 51, 102-12.
- Singh S, Tang SJ, Sreenarasimhaiah J, et al (2011). The clinical utility and limitations of serum carbohydrate antigen (CA19-9) as a diagnostic tool for pancreatic cancer and cholangiocarcinoma. Dig Dis Sci, 56, 2491-6. https://doi.org/10.1007/s10620-011-1709-8
- Wagner M, Naik DN, Pothen A, et al (2004). Computational protein biomarker prediction: a case study for prostate cancer. BMC Bioinformatics, 5, 26. https://doi.org/10.1186/1471-2105-5-26
- Ward DG, Cheng Y, N'Kontchou G, et al (2006). Preclinical and post-treatment changes in the HCC-associated serum proteome. Br J Cancer, 95, 1379-83. https://doi.org/10.1038/sj.bjc.6603429
- Ward DG, Suggett N, Cheng Y, et al (2006). Identification of serum biomarkers for colon cancer by proteomic analysis. Br J Cancer, 94, 1898-905. https://doi.org/10.1038/sj.bjc.6603188
피인용 문헌
- Biomarkers Screening Between Preoperative and Postoperative Patients in Pancreatic Cancer vol.14, pp.7, 2013, https://doi.org/10.7314/APJCP.2013.14.7.4161
- Identification of patients with nasopharyngeal carcinoma by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry vol.19, pp.4, 2014, https://doi.org/10.1007/s10147-013-0621-y
- Alterations in the serum proteome profile during the development of ovarian cancer vol.45, pp.6, 2014, https://doi.org/10.3892/ijo.2014.2675
- Serum protein profiles of patients with lung cancer of different histological types vol.12, pp.1, 2016, https://doi.org/10.1111/ajco.12441
- Pancreatic cancer: diagnosis and treatments vol.36, pp.3, 2015, https://doi.org/10.1007/s13277-015-3223-7